Literature DB >> 16378705

Capillary electrophoretic analysis of the antibiotic vancomycin in innovative microparticles and in commercial formulations.

A Musenga1, R Mandrioli, V Zecchi, B Luppi, S Fanali, M A Raggi.   

Abstract

A new fast capillary electrophoretic method has been developed for the analysis of the glycopeptide antibiotic vancomycin in formulations. An electrophoretic run is completed within 3.0 min; fused silica capillaries (100 microm i.d., 8.5 cm effective length and 48.5 cm total length) and a background electrolyte consisting of 12.5 mM, pH 2.5 phosphate buffer are used. The applied voltage is -20.0 kV; samples are injected by pressure (30 mbar x 3 s) at the anodic end of the capillary. The method was successfully applied to innovative controlled release microparticles consisting of a coated albumin core containing vancomycin. A simple procedure has been developed to obtain complete vancomycin extraction from microparticles using a 5% (w/v) sodium dodecyl sulphate aqueous solution. The method has been validated in terms of linearity, precision and accuracy. Good linearity was found in the 0.25-5.00 microg/mL range. Satisfactory precision was obtained, with relative standard deviation values always lower than 3.9%; accuracy was satisfactory, with recovery values between 97.8 and 102.2%. The method is also suitable for vancomycin determination in commercial capsules.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16378705     DOI: 10.1016/j.jpba.2005.11.022

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

Review 1.  Recent developments in CE and CEC of peptides.

Authors:  Václav Kasicka
Journal:  Electrophoresis       Date:  2008-01       Impact factor: 3.535

2.  Utility of Silver-nanoparticles for Nano-fluorimetric Determination of Vancomycin Hydrochloride in Pharmaceutical Formulation and Biological Fluids: Greenness Assessment.

Authors:  Ahmed R Mohamed
Journal:  J Fluoresc       Date:  2022-06-25       Impact factor: 2.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.